Shareholding disclosure

Cytos Biotechnology AG

Declared position

20.4%

Threshold

Crossed upwards

Timeline

Published

10.06.2009

Transaction

08.06.2009

Transfer date

08.06.2009

Voting rights breakdown

Voting rights acquired20.4%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TA96900027

Beneficial owner

Cytos Biotechnology AG

Declared address

Cytos Biotechnology AG, 8952 Schlieren

Zuteilung von Mitarbeiteroptionen

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Cytos Biotechnology AG

Kuros Biosciences AG10.06.2009TA96900027

Disclosure summary

Cytos Biotechnology AG disclosed a holding in Kuros Biosciences AG on the acquisition side, published by SIX Exchange Regulation on 10.06.2009, at 20.4% of voting rights. Notice category: Single shareholder.

Disclosed position

20.4%

Voting rights acquired

Voting rights acquired20.4%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Cytos Biotechnology AG disclosed a holding in Kuros Biosciences AG, published on 10.06.2009.

Publication date10.06.2009

Transaction date08.06.2009

Transfer date08.06.2009

Issuing companyKuros Biosciences AG

Beneficial ownerCytos Biotechnology AG

Declared addressCytos Biotechnology AG, 8952 Schlieren

CategorySingle shareholder

Voting rights acquired20.4%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTA96900027

Commercial register

CHE-104.785.642

Registered

Zefix record

Conditions

Zuteilung von Mitarbeiteroptionen

Source: SIX Exchange Regulation · Publication date: 10.06.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open